2023
DOI: 10.1016/j.neuropharm.2022.109376
|View full text |Cite
|
Sign up to set email alerts
|

The life and times of endogenous opioid peptides: Updated understanding of synthesis, spatiotemporal dynamics, and the clinical impact in alcohol use disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 347 publications
0
2
0
Order By: Relevance
“…4D). The key interactions are in the central region of the peptide: during design, we excluded the N-terminal YGGF sequence which is shared between dynorphin A and B and other neuropeptides 32 , aiming to distinguish closely related peptides in the family where antibodies often fail, and the C-terminal region (-WDNQ) which is missing in some species (Fig. 4E).…”
Section: Structural Validationmentioning
confidence: 99%
“…4D). The key interactions are in the central region of the peptide: during design, we excluded the N-terminal YGGF sequence which is shared between dynorphin A and B and other neuropeptides 32 , aiming to distinguish closely related peptides in the family where antibodies often fail, and the C-terminal region (-WDNQ) which is missing in some species (Fig. 4E).…”
Section: Structural Validationmentioning
confidence: 99%
“…There is a strong precedent for the importance of opioid signaling in the striatum, with extensive literature pointing to numerous striatal functions of other endogenous opioid systems, most notably mu and kappa, in the coordination of key reward and feeding behaviors ((Bodnar et al 1995, Ragnauth et al 2000, Castro and Berridge 2014, Castro and Bruchas 2019, Castro et al 2021). In addition, dysregulated striatal opioid signaling can contribute to a wide range of neurological disorders including mood disorders, substance use disorder, Huntington’s disease, Parkinson’s disease, and schizophrenia among others (Sgroi and Tonini 2018, Cui et al 2014b, Banghart et al 2015, Margolis et al 2023, Morigaki et al 2020, Kennedy et al 2006, Canales and Graybiel 2000, Clark and Abi-Dargham 2019), in part owing to the distinct patterns of expression exhibited by different opioid receptors and peptides throughout striatum, including differential expression in striosome and matrix compartments (Crittenden and Graybiel 2011, Graybiel 1990, Brimblecombe and Cragg 2017, Tajima and Fukuda 2013). Although Pnoc -expressing neurons can be found throughout the striatum, their organization within striatal neuronal types and their anatomical intersection with dopamine circuitry across striatal subregions have remained largely unknown, especially in comparison to the other striatal opioid systems.…”
Section: Introductionmentioning
confidence: 99%